Bleomycin

chemokine (C-C motif) receptor 2 ; Mus musculus







10 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32096250 Antifibrogenic effects of C-C chemokine receptor type 2 antagonist in a bleomycin-induced scleroderma model. 2021 Jan 2
2 32673071 Chemokine Receptor 2-targeted Molecular Imaging in Pulmonary Fibrosis. A Clinical Trial. 2021 Jan 1 1
3 32253243 IRAK-M Regulates Monocyte Trafficking to the Lungs in Response to Bleomycin Challenge. 2020 May 15 1
4 30470612 Evaluation of the antifibrotic potency by knocking down SPARC, CCR2 and SMAD3. 2018 Dec 1
5 27777976 Epithelial-macrophage interactions determine pulmonary fibrosis susceptibility in Hermansky-Pudlak syndrome. 2016 Oct 20 1
6 24507087 Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis. 2014 Feb 8 1
7 15538737 C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases. 2004 Dec 4
8 12925209 Role of monocyte chemoattractant protein-1 and its receptor,CCR-2, in the pathogenesis of bleomycin-induced scleroderma. 2003 Sep 3
9 14609568 CC-chemokine receptor 2 required for bleomycin-induced pulmonary fibrosis. 2003 Dec 21 1
10 11591761 Protection from pulmonary fibrosis in the absence of CCR2 signaling. 2001 Oct 15 1